Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry.
Biomarker-targeted surface-enhanced Raman scattering (SERS) nanoparticles (NPs) have been explored as a viable option for targeting and imaging multiple cell-surface protein biomarkers of cancer. While it has been demonstrated that this Raman-encoded molecular imaging (REMI) technology may potentially be used to guide tumor-resection procedures, the REMI strategy would benefit from further improvements in imaging speed. Previous implementations of REMI have utilized 1024 spectral channels (camera pixels) in a commercial spectroscopic CCD to detect the spectral signals from multiplexed SERS NPs, a strategy that enables accurate demultiplexing of the relative concentration of each NP "flavor" within a mixture. Here, we investigate the ability to significantly reduce the number of spectral-collection channels while maintaining accurate imaging and demultiplexing of up to five SERS NP flavors, a strategy that offers the potential for improved imaging speed and/or detection sensitivity in future systems. This strategy was optimized by analyzing the linearity of five multiplexed flavors of SERS NPs topically applied on tissues. The accuracy of this binning approach was then validated by staining tumor xenografts and human breast tumor specimens with a mixture of five NP flavors (four targeted NPs and one untargeted NP) and performing ratiometric imaging of specific vs. nonspecific NP accumulation. We demonstrate that with channel-compressed spectrometry using as few as 16 channels, it is possible to perform REMI with five NP flavors, with < 20% error, at low concentrations (< 10 pM) that are relevant for clinical applications.
Department of Mechanical Engineering, University of Washington, Seattle, WA, United States of America.
Soyoung
http://orcid.org/0000-0002-1022-9648
S
Kang
Department of Mechanical Engineering, University of Washington, Seattle, WA, United States of America.
Yu
Y
Wang
Department of Pathology, University of Washington Medical Center, Seattle, WA, United States of America.
Nicholas P
NP
Reder
Department of Mechanical Engineering, University of Washington, Seattle, WA, United States of America.
Jonathan T C
JT
Liu
Technology (Singap World Sci). 2014 Jun 1;2(2):118-132
25045721
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):E2288-97
23703909
Ann Surg Oncol. 2005 Nov;12(11):881-5
16195834
J Biomed Opt. 2013 Sep;18(9):096008
24008818
J Biomed Opt. 2012 Jun;17(6):066001
22734757
Sci Rep. 2015 Feb 26;5:8582
25716578
PLoS One. 2013 Apr 19;8(4):e62084
23620806
N Engl J Med. 2012 Mar 8;366(10):956-7
22397658
Ann Nucl Med. 2006 Jan;20(1):1-11
16485568
Anal Chem. 2010 Nov 1;82(21):9058-65
20925393
Surgery. 2002 Mar;131(3):311-7
11894036
Am J Surg. 2009 Dec;198(6):771-80
19969128
Nat Rev Clin Oncol. 2013 Sep;10(9):507-18
23881033
Am J Surg. 2012 Jul;204(1):66-77
22178485
N Engl J Med. 2012 Mar 8;366(10):883-92
22397650
Ann Surg Oncol. 2009 Oct;16(10):2717-30
19609829
IEEE J Sel Top Quantum Electron. 2016 Jul-Aug;22(4):null
27524875
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13511-6
19666578
Sci Rep. 2016 Feb 16;6:21242
26878888
Biophys J. 2009 Mar 18;96(6):2405-14
19289065
Head Neck. 2013 Sep;35(9):1362-70
22941934
J Biomed Opt. 2013 Apr;18(4):046011
23591913
Biomed Opt Express. 2015 Sep 01;6(10):3714-23
26504623
Mol Imaging Biol. 2012 Oct;14(5):584-92
22203241
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
25559415
Nat Med. 2014 Nov;20(11):1348-53
25344739
Chem Rev. 2013 Mar 13;113(3):1391-428
23273312
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71
24890451
Biomed Opt Express. 2014 Aug 01;5(9):2883-95
25401005
Ann Surg Oncol. 2014 Mar;21(3):717-30
24473640
J Urol. 2013 Nov;190(5):1674-9
23764077
Nat Med. 2011 Sep 18;17(10):1315-9
21926976
Cancer Res. 1978 Sep;38(9):2651-60
354778
Neurosurgery. 2008 Apr;62(4):753-64; discussion 264-6
18496181